Rare
lephants
Screener
Toggle theme
Smith & Nephew plc
SNN
·
Healthcare, Medical Devices
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
Total Cash from Operations:
$1.29B
Line Item
Value
% of Total
Capital Expenditures
$400.9M
31.2%
Stock Repurchases
$502.0M
39.1%
Other Financing
$382.1M
29.7%
Net Cash Flow
$0
0.0%
Download CSV
